Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram
Short descriptor: Inj, releuko 1 mcg
Look up Q5125 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.
Q5125 is the HCPCS Level II code for Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram (2026). It belongs to Section Q — Temporary Codes. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Drugs.
Classification & CMS Attributes
- Section
- Q: Temporary Codes
- Medicare Coverage
- Carrier judgment (code C)
- Part B Pricing
- Drugs (indicator 51)
- Type of Service
- Medical care
- Effective Date
- 2022-10-01
- 2026 Maintenance
- No change this year
References
Cite This Page
Reference Q5125 with the canonical source and edition:
Q5125 — Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/Q5125
Canonical URL: https://icd10codingpro.com/hcpcs-codes/Q5125